IME Share Price Performance
AU$0.39
0.05 (13.04%)
62.5% undervalued intrinsic discount
AU$1.04
Fair Value
Price AU$0.39
Wobbegong AU$1.04
AnalystConsensusTarget AU$0.50
Fair ValueAU$1.04
Share Pricen/a
ImExHS Limited Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
IME Community Narratives
WO
Fair Value AU$1.04 62.5% undervalued intrinsic discount
Plenty of upside
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value AU$0.5 22.0% undervalued intrinsic discount
Cloud Adoption And AI Integration Will Support A Stronger Long Term Outcome
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Plenty of upside
The quarterly release indiates the company is getting through to profitability and cashflow sustainability. Management team seems to have done a good job across the board – cash, price, volume, renegotiations, cost control, efficiency, etc.Read more
12
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
WO
AU$1.04
62.5% undervalued intrinsic discount
Fair Value
Profit Margin
13.77%
Future PE
31.32x
Price in 2031
AU$1.53
Cloud Adoption And AI Integration Will Support A Stronger Long Term Outcome
Catalysts About ImExHS ImExHS provides cloud-native medical imaging software and outsourced radiology services that support hospitals, clinics and diagnostic centers across multiple countries. What are the underlying business or industry changes driving this perspective?Read more
3
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AU$0.5
22.0% undervalued intrinsic discount
Fair Value
Profit Margin
13.07%
Future PE
6.59x
Price in 2029
AU$0.63
Trending Discussion
Recently Updated Narratives
WO
Plenty of upside
Fair Value: AU$1.04 62.5% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Cloud Adoption And AI Integration Will Support A Stronger Long Term Outcome
Fair Value: AU$0.5 22.0% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
ImExHS Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.053
- 44.77%
- -9.95%
- 3.3%
About IME
- Founded
- 2001
- Employees
- 290
- CEO
- WebsiteView website
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists’ interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.
